Market News / Story
iBio, Inc. Stock 12‑Month Price Target Cut to $5.53, Implies 447% Upside
·
According to estimates from 8 analysts, iBio, Inc. stock's average price target has fallen from $5.69 to $5.53, with forecasts ranging from $4.2 to $7 per share Based on the Oct. 7 closing price, the updated target implies approximately 447% potential upside Consensus rating remains at “Buy” across 8 covering analysts, with 8 Buys, 0 Holds and 0 Sells Explore more price target data and ratings for iBio, Inc. on the Forecasts tab , and track all previous and future…